SBI Securities’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

SBI Securities’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-50	Closed	-$26	–	4278
2025 Q1	$26	Hold	50	–	–	﹤0.01%	3801
2024 Q4	$263	Buy	+50	New	+$328	﹤0.01%	3141

Other funds holding VINC

BTC

Bank & Trust Company Litchfield, Illinois $158M AUM 35.48% 1-Year Est. Return

SBI Securities's VINC Position: Q2 2025 in Review

SBI Securities sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q2 2025, closing a stake of 50 shares — an estimated $26 sold.

SBI Securities first reported a position in VINC in Q4 2024 and held it in 2 quarters. The position peaked at $263 in Q4 2024. 1 fund tracked by Wall St. Rank holds VINC as of Q2 2025.

SBI Securities reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
SBI Securities sold 50 Vincerx Pharma, Inc. Common Stock shares in Q2 2025, an estimated $26.
SBI Securities first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
SBI Securities's Vincerx Pharma, Inc. Common Stock position peaked at $263 in Q4 2024.
1 fund tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q2 2025.

Based on SBI Securities's 13F filing for Q2 2025, filed 8 Aug 2025.